Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Nov 15;64(10):904-6.
doi: 10.1016/j.biopsych.2008.07.004. Epub 2008 Aug 22.

Decreased cognition in children with risk factors for Alzheimer's disease

Affiliations

Decreased cognition in children with risk factors for Alzheimer's disease

Cinnamon S Bloss et al. Biol Psychiatry. .

Abstract

Background: The epsilon4 allele of the apolipoprotein E gene (APOE-epsilon4) and a family history (+FH) of Alzheimer's disease (AD) are both risk factors for the development of AD. Although studies to identify a preclinical phase of AD have led to evidence of APOE-epsilon4- and +FH-related differences in brain and cognitive functioning in healthy adults, the relative influence of these factors in children is unknown.

Methods: To investigate this issue, school-age children (n = 109) received standardized achievement tests, the Rey-Osterrieth Complex Figure Test (Copy Condition; RCFT-CC), assessment of family medical history, and buccal swab testing to determine their APOE genotype.

Results: Analyses revealed that, relative to children without these risk factors, children who possess both an APOE-epsilon4 allele and a +FH of AD and/or significant memory problems (MP) obtained lower scores on nearly every cognitive test administered.

Conclusions: Findings suggest that when both AD risk factors are present, cognition may be adversely affected as early as childhood. Thus, risk factors for a disorder of pathological aging (i.e., AD) may have implications for the etiology of certain types of learning difficulties in children.

PubMed Disclaimer

Conflict of interest statement

Financial Disclosures

The authors report no biomedical financial interests or potential conflicts of interest.

References

    1. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 1993;90(5):1977–1981. - PMC - PubMed
    1. Small BJ, Rosnick CB, Fratiglioni L, Backman L. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging. 2004;19(4):592–600. - PubMed
    1. Cupples LA, Farrer LA, Sadovnick AD, Relkin N, Whitehouse P, Green RC. Estimating risk curves for first-degree relatives of patients with Alzheimer’s disease: the REVEAL study. Genet Med. 2004;6(4):192–196. - PubMed
    1. Johnson SC, Schmitz TW, Trivedi MA, Ries ML, Torgerson BM, Carlsson CM, et al. The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J Neurosci. 2006;26(22):6069–6076. - PMC - PubMed
    1. Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF, et al. Cognitive change and the APOE epsilon 4 allele. Nature. 2002;418(6901):932. - PubMed

Publication types

Substances